Azmi Nabulsi - May 19, 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
Stock symbol
PHAT
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 05:19 PM
Previous filing
May 16, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +12K +56.13% $0.00 33.4K May 19, 2022 Direct F1
holding PHAT Common Stock 843 May 19, 2022 by 401(k)
holding PHAT Common Stock 786K May 19, 2022 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on May 19, 2022. One third (1/3) of the total number of RSUs granted vest on November 19, 2022, May 19, 2023 and November 19, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.